The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A qPCR gene expression module test to predict resistance to cetuximab in colorectal cancers independent of KRAS mutation status.
Dan Rhodes
Employment or Leadership Position - Compendia Bioscience
Stock Ownership - Compendia Bioscience
Sean Eddy
Employment or Leadership Position - Compendia Bioscience
Paul Williams
Employment or Leadership Position - Compendia Bioscience
Mark Tomilo
Employment or Leadership Position - Compendia Bioscience
Seth Sadis
Employment or Leadership Position - Compendia Bioscience
Peter Wyngaard
Employment or Leadership Position - Compendia Bioscience
Stock Ownership - Compendia Bioscience
Lien Vo
Employment or Leadership Position - AltheaDx
Kahuku Oades
Employment or Leadership Position - AltheaDx
Stock Ownership - AltheaDx
Hyunsoo Kim
Employment or Leadership Position - AltheaDx
Yipeng Wang
Employment or Leadership Position - AltheaDx
Byung-In Lee
Employment or Leadership Position - AltheaDx
Stock Ownership - AltheaDx
Joseph Monforte
Employment or Leadership Position - AltheaDx
Stock Ownership - AltheaDx